Management of rare movement diseases in different world regions
Cèlia Painous(Biomedical Research Networking Center on Neurodegenerative Diseases), Marina A.J. Tijssen(University Medical Center Groningen), Houyam Tibar, Andrea Paola Camargo(Fundación Universitaria de Ciencias de la Salud), Funmilola Taiwo(University College Hospital, Ibadan), Mary F. Kearney, Roopa Rajan(All India Institute of Medical Sciences), Biniyam A. Ayele(Addis Ababa University), Oluwadamilola O. Ojo(University of Lagos), Marı́a José Martı́(Biomedical Research Networking Center on Neurodegenerative Diseases), Daniel Martínez-Ramírez(Tecnológico de Monterrey), Holm Graeßner(University Children's Hospital Tübingen), Mario Cornejo‐Olivas(Universidad Científica del Sur), Emilia Gatto(Universidad de Buenos Aires), Shaimaa I El-Jaafary(Cairo University)
Cited by 3
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders
|Aging & Mental Health|2018|57
Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial
|Journal of Pain Research|2016|47
Occupational metals exposure and cognitive performance among foundry workers using tau protein as a biomarker
|NeuroToxicology|2019|31
Epilepsy and antiepileptic drugs: risk factors for atherosclerosis
|International Journal of Neuroscience|2014|26